Center for Cancers and Blood Disorders
- Research works
- 24 ▼ 47% vs 2013–17
- Citations
- 430 17.6 per fractional work
- Top-10% rate
- 7.9% record average 16.5%
- Open access
- 34% world 28%
Not ranked overall: Center for Cancers and Blood Disorders is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.6×. Every wedge is a field page.
Which keywords describe research at Center for Cancers and Blood Disorders?
By fractional works in all years, weighted toward what it does more of than the world: Anemia, Epidemiology, Iron Deficiency, Revision Surgery, Total Hip Replacement, Lymphoma, Inflammation and Chemotherapy.
- Pulmonary Hypertension
- Chronic Kidney Disease
- Immunotherapy
- Chemotherapy
- Total Hip Replacement
- Oxidative Stress
- Iron Deficiency
- Epidemiology
- Anemia
- Inflammation
- Lymphoma
- Revision Surgery
- Cardiovascular Disease
- Hemorrhage
- Cancer Therapy
- Clinical Trials
- Cancer Treatment
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Anemia3▲ 108×4 topics
- Epidemiology3▲ 2.8×12 topics
- Inflammation2▲ 3.2×8 topics
- Iron Deficiency2▲ 113×2 topics
- Lymphoma1▲ 36×3 topics
- Oxidative Stress1▲ 2.9×8 topics
- Revision Surgery1▲ 46×2 topics
- Total Hip Replacement1▲ 46×2 topics
- Cardiovascular Disease1▲ 4.4×3 topics
- Chemotherapy1▲ 7.2×11 topics
- Hemorrhage1▲ 65×2 topics
- Immunotherapy1▲ 7.3×8 topics
- Cancer Therapy1▲ 7.2×9 topics
- Chronic Kidney Disease1▲ 19×3 topics
- Clinical Trials1▲ 7.3×4 topics
- Pulmonary Hypertension1▲ 27×3 topics
- Cancer Treatment1▲ 16×2 topics
Which research topics does Center for Cancers and Blood Disorders publish most on?
By volume in 2022–2025: Hemoglobinopathies and Related Disorders, Biomedical Ethics and Regulation, Immune cells in cancer and Epigenetics and DNA Methylation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemoglobinopathies and Related Disorders Genetics 1 works
- 2 Biomedical Ethics and Regulation Physiology 0 works
- 3 Immune cells in cancer Immunology 0 works
- 4 Epigenetics and DNA Methylation Molecular Biology 0 works
- 5 Histone Deacetylase Inhibitors Research Molecular Biology 0 works
- 6 Blood transfusion and management Biochemistry 0 works
- 7 Blood groups and transfusion Hematology 0 works
- 8 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
- 9 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 10 Lung Cancer Research Studies Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Center for Cancers and Blood Disorders's research output changed?
Output in 2018–2022 was 47% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bethesda
- National Institutes of Health
- National Cancer Institute
- Uniformed Services University of the Health Sciences
- National Institute of Allergy and Infectious Diseases
- Lockheed Martin (United States)
- National Heart Lung and Blood Institute
- National Institute of Mental Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.